Qianming Du

2.3k total citations
52 papers, 1.8k citations indexed

About

Qianming Du is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Qianming Du has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Immunology. Recurrent topics in Qianming Du's work include Immune cells in cancer (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Inflammasome and immune disorders (7 papers). Qianming Du is often cited by papers focused on Immune cells in cancer (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Inflammasome and immune disorders (7 papers). Qianming Du collaborates with scholars based in China, United States and United Kingdom. Qianming Du's co-authors include Rong Hu, Xiuting Liu, Chao Liu, Yubing Zhu, Jianing Wang, Yajing Wang, Jianjun Zou, Wei Zhou, Yang Ding and Ping Lü and has published in prestigious journals such as ACS Nano, Scientific Reports and The FASEB Journal.

In The Last Decade

Qianming Du

52 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qianming Du China 23 982 458 345 240 144 52 1.8k
Xuechun Li China 18 893 0.9× 262 0.6× 329 1.0× 369 1.5× 111 0.8× 48 2.0k
Ting Zhao China 26 865 0.9× 257 0.6× 239 0.7× 231 1.0× 237 1.6× 141 2.2k
Chun‐Yin Huang Taiwan 30 1.2k 1.2× 321 0.7× 463 1.3× 411 1.7× 198 1.4× 60 2.2k
Antonio Luciano Italy 24 712 0.7× 468 1.0× 582 1.7× 161 0.7× 70 0.5× 54 1.7k
Megumi Funakoshi‐Tago Japan 28 1.0k 1.1× 490 1.1× 398 1.2× 212 0.9× 93 0.6× 101 2.3k
Qinghua Lu China 26 988 1.0× 206 0.4× 282 0.8× 263 1.1× 229 1.6× 70 1.9k
Min Young Lee South Korea 30 1.6k 1.7× 346 0.8× 293 0.8× 479 2.0× 145 1.0× 110 2.6k
Zahra Asadzadeh Iran 23 668 0.7× 458 1.0× 573 1.7× 320 1.3× 75 0.5× 45 1.7k

Countries citing papers authored by Qianming Du

Since Specialization
Citations

This map shows the geographic impact of Qianming Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianming Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianming Du more than expected).

Fields of papers citing papers by Qianming Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianming Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianming Du. The network helps show where Qianming Du may publish in the future.

Co-authorship network of co-authors of Qianming Du

This figure shows the co-authorship network connecting the top 25 collaborators of Qianming Du. A scholar is included among the top collaborators of Qianming Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianming Du. Qianming Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ren, Shuang, Jiyuan Zhang, Jianqing Peng, et al.. (2024). Design of a targeted dual drug delivery system for boosting the efficacy of photoimmunotherapy against melanoma proliferation and metastasis. Journal of Advanced Research. 71. 533–550. 6 indexed citations
3.
Zhou, Jia, Runbin Sun, Di Pan, et al.. (2024). Comparison of cell delivery and cell membrane camouflaged PLGA nanoparticles in the delivery of shikonin for colorectal cancer treatment. Colloids and Surfaces B Biointerfaces. 241. 114017–114017. 7 indexed citations
4.
Tian, Yucheng, Kang Liu, Dongdong Wu, et al.. (2024). The discovery of potent USP2/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364. European Journal of Medicinal Chemistry. 268. 116275–116275. 2 indexed citations
5.
Qin, Xia, et al.. (2024). Pre-coating cRGD-modified bovine serum albumin enhanced the anti-tumor angiogenesis of siVEGF-loaded chitosan-based nanoparticles by manipulating the protein corona composition. International Journal of Biological Macromolecules. 267(Pt 2). 131546–131546. 8 indexed citations
6.
Li, Tao, Bin Fu, Mengdi Yang, et al.. (2024). Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane. Drug Resistance Updates. 76. 101112–101112. 11 indexed citations
7.
8.
Zhang, Di, Tian Chen, Yuqing Zhang, et al.. (2023). Discovery of thiohydantoin based antagonists of androgen receptor with efficient degradation for the treatment of prostate cancer. European Journal of Medicinal Chemistry. 257. 115490–115490. 2 indexed citations
9.
Yan, Hui, Qiang Zhou, Fang Yang, et al.. (2023). CCNB1IP1 prevents ubiquitination‐mediated destabilization of MYCN and potentiates tumourigenesis of MYCN‐amplificated neuroblastoma. Clinical and Translational Medicine. 13(7). e1328–e1328. 5 indexed citations
10.
Yan, Hui, Lulu Liu, Bo Zhai, et al.. (2023). Application of curcumin as a co-former and an efflux inhibitor in paclitaxel co-amorphous mixture. Journal of Drug Delivery Science and Technology. 84. 104513–104513. 9 indexed citations
11.
Peng, Jianqing, Jia Zhou, Runbin Sun, et al.. (2023). Dual-targeting of artesunate and chloroquine to tumor cells and tumor-associated macrophages by a biomimetic PLGA nanoparticle for colorectal cancer treatment. International Journal of Biological Macromolecules. 244. 125163–125163. 31 indexed citations
12.
Zhang, Chunxue, Yuxiang Fei, Hui Wang, et al.. (2023). CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?. Frontiers in Pharmacology. 14. 67 indexed citations
13.
Li, Tao, Mengdi Yang, Qianming Du, et al.. (2022). Acquired temozolomide resistance in MGMTlow gliomas is associated with regulation of homologous recombination repair by ROCK2. Cell Death and Disease. 13(2). 138–138. 15 indexed citations
14.
Peng, Jianqing, Qin Wang, Jia Zhou, et al.. (2021). Targeted Lipid Nanoparticles Encapsulating Dihydroartemisinin and Chloroquine Phosphate for Suppressing the Proliferation and Liver Metastasis of Colorectal Cancer. Frontiers in Pharmacology. 12. 720777–720777. 18 indexed citations
15.
Chen, Yi, Qianming Du, Ying Zou, et al.. (2020). Co-delivery of doxorubicin and epacadostat via heparin coated pH-sensitive liposomes to suppress the lung metastasis of melanoma. International Journal of Pharmaceutics. 584. 119446–119446. 27 indexed citations
16.
Liu, Xiuting, Wei Zhou, Xin Zhang, et al.. (2018). 1‐L‐MT, an IDO inhibitor, prevented colitis‐associated cancer by inducing CDC20 inhibition‐mediated mitotic death of colon cancer cells. International Journal of Cancer. 143(6). 1516–1529. 48 indexed citations
17.
Zhang, Xu, Qianming Du, Yan Yang, et al.. (2018). Salidroside alleviates ischemic brain injury in mice with ischemic stroke through regulating BDNK mediated PI3K/Akt pathway. Biochemical Pharmacology. 156. 99–108. 51 indexed citations
18.
Zhang, Xu, Qianming Du, Yang Yan, et al.. (2017). The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway. Biomedicine & Pharmacotherapy. 91. 1042–1052. 127 indexed citations
19.
Du, Qianming, Qing Wang, Huimin Fan, et al.. (2016). Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome. Biochemical Pharmacology. 105. 42–54. 84 indexed citations
20.
Zhang, Xu, Qianming Du, Chao Liu, et al.. (2016). Rhodioloside ameliorates depressive behavior via up-regulation of monoaminergic system activity and anti-inflammatory effect in olfactory bulbectomized rats. International Immunopharmacology. 36. 300–304. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuechun Li Breakdown of academic impact, for papers by Ting Zhao Breakdown of academic impact, for papers by Chun‐Yin Huang Breakdown of academic impact, for papers by Antonio Luciano Breakdown of academic impact, for papers by Megumi Funakoshi‐Tago Breakdown of academic impact, for papers by Qinghua Lu Breakdown of academic impact, for papers by Min Young Lee Breakdown of academic impact, for papers by Zahra Asadzadeh
Rankless by CCL
2026